New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions
NEW YORK, Sept. 20, 2022 -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today two new employer contracts, including one for the full suite of integrated solutions. The new accounts are scheduled to launch in late 2022 and early 2023.
Through the first contract, Dario will deliver its full suite of integrated solutions to a leading global manufacturer. The second contract is for Dario's behavioral health solution with an integrated Employee Assistance Program (EAP). This contract originated through an existing employer channel partnership and demonstrates the value of Dario's recently announced strategic relationships in the market.
The new multi-chronic account also reflects the growing demand for Dario's integrated, holistic digital health solutions to address commonly co-occurring chronic conditions. Dario's single digital therapeutics platform is designed to make it easier for people to manage chronic health conditions with highly personalized experiences informed by billions of insights gained from more than ten years of engaging consumers.
"We continue to see strong demand in the employer market thanks to our seamless and highly effective approach to helping people access support for a variety of chronic health needs. We are excited to welcome these new companies as customers and introduce their employees to a better way to care for their health," said Rick Anderson, President of Dario.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Dario's user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com, the content of which is not incorporated by reference into this press release.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected timing of the contract launches, the potential benefits that may be realized by users utilizing the Dario platform, that the contract demonstrates the value of its recently announced strategic relationships in the market, and the growing demand for its integrated, holistic digital health solutions. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
DarioHealth Corporate Contact
SOURCE DarioHealth Corp.